Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IFF sells NY headquarters

This article was originally published in The Rose Sheet

Executive Summary

Sale of global headquarters building in New York will yield proceeds of approximately $90 mil., which will be used to "substantially" reduce debt and "further improve" overall return on capital, International Flavors & Fragrances announces May 13. Transaction expected to close in June. IFF has signed a long-term lease for space it currently occupies in the building, firm notes. In Q1, IFF reported total net debt of $294.4 mil. and announced opening of salon at headquarters to serve as base for fragrance development in hair care (1"The Rose Sheet" May 5, 2003, p. 6)...

You may also be interested in...

IFF-Based Salon Opened To Promote Hair Care Fragrance Development

International Flavors & Fragrances has opened a hair salon at its global headquarters in Manhattan to serve as a base for fragrance development in hair care, the company announced April 28. The facility will be run in partnership with salon operator Anderson French

US FDA Still Seeking Sponsor Cooperation For Oncology Label Updates

Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.

Oncology Drug Safety Is Key Focus In US FDA’s Generic Label Updates

US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts